Last reviewed · How we verify

NCT03920046

Effects of Passive Smoking on Children During Gastrointestinal Endoscopy

Completed Last updated 16 March 2021
What this trial tests

trial testing Control Group in Gastro-Intestinal Disorders in 518 participants. Completed in 1 March 2021.

Timeline
2 January 2019
Primary endpoint
1 March 2021
1 March 2021

Quick facts

Lead sponsorTC Erciyes University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment518
Start date2 January 2019
Primary completion1 March 2021
Estimated completion1 March 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

TC Erciyes University

Who can join

Adults 1 to 18, any sex, with Gastro-Intestinal Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effect of passive smoking in children during Gastrointestinal Endoscopy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of passive smoking on the laryngospasm rate in children sedated during the esophagogastroduodenoscopy.
    Pehlıvan SS, Gergın OO, Bayram A, Altay D, et al · · 2022 · cited 4× · PMID 35256495 · DOI 10.15537/smj.2022.43.3.20210784

Verify or expand the search:

Other trials of Control Group

Trials testing the same drug.

Other TC Erciyes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03920046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing